Clinical trial · Interventional
20-Fr Versus 24-Fr Chest Drains After Uniportal VATS Lobectomy for NSCLC
Prospective Randomized Comparative Evaluation of Different Chest Drainage Devices in Patients Undergoing Lung Lobectomy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 19, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260919-000001
Summary
Brief summary (as posted)
This randomized clinical trial compared two different chest drain sizes, 20 Fr and 24 Fr, in patients undergoing lung lobectomy for lung cancer. The study aimed to determine whether the size of the chest drain affects postoperative recovery. Outcomes included the presence of pneumothorax and pleural effusion, postoperative pain, subcutaneous emphysema, prolonged air leak, duration of chest drainage, and length of hospital stay. A total of 80 patients were randomly assigned in a 1:1 ratio to receive either a 20-Fr or a 24-Fr chest drain.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-Small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| 20-Fr Thoracic Drain | Device | — | UNRESOLVED |
| 24-Fr Thoracic Drain | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- 20-Fr Chest Drain
- description
- Patients undergoing uniportal video-assisted thoracoscopic lobectomy with systematic mediastinal lymphadenectomy received a 20-Fr thoracic drain at the end of surgery.
- interventionNames
- Device: 20-Fr Thoracic Drain
- type
- ACTIVE_COMPARATOR
- label
- 24-Fr Chest Drain
- description
- Patients undergoing uniportal video-assisted thoracoscopic lobectomy with systematic mediastinal lymphadenectomy received a 24-Fr thoracic drain at the end of surgery.
- interventionNames
- Device: 24-Fr Thoracic Drain
Primary outcomes (2)
- measure
- Postoperative Pneumothorax (PNX)
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients undergoing pulmonary lobectomy with systematic mediastinal lymphadenectomy for lung cancer using a uniportal video-assisted thoracoscopic approach. * FEV1/FVC \>70%. * Clinical stage up to and including stage IIB according to the eighth or ninth edition of the TNM classification. * No morphological evidence of macrobullous emphysema on computed tomography. Exclusion Criteria: * Neoadjuvant chemoradiotherapy. * Previous ipsilateral pulmonary resection. * FEV1/FVC \<70%. * Clinical stage beyond IIB according to the eighth or ninth edition of the TNM classification. * Macrobullous emphysema on computed tomography. * pregnant and breastfeeding women
References
Publications (0)
Data not yet available